Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.
about
Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma PatientsNon-standard radiotherapy fractionations delay the time to malignant transformation of low-grade gliomas.Lack of robustness of textural measures obtained from 3D brain tumor MRIs impose a need for standardization.Preoperative albumin-to-globulin ratio and prognostic nutrition index predict prognosis for glioblastoma
P2860
Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.
@en
Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.
@nl
type
label
Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.
@en
Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.
@nl
prefLabel
Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.
@en
Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.
@nl
P2093
P2860
P50
P1433
P1476
Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study
@en
P2093
Ana Del Valle
Anthony Falkov
Beatriz Asenjo
Belén Luque
Carlos López
David Albillo
David Molina
Elena Arregui
Estanislao Arana
Ismael Herruzo
P2860
P2888
P304
P356
10.1007/S00330-016-4453-9
P407
P50
P577
2016-06-21T00:00:00Z